洁特生物
(688026)
| 流通市值：22.25亿 | | | 总市值：22.26亿 |
| 流通股本：1.40亿 | | | 总股本：1.40亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 302,498,940.36 | 284,205,896.01 | 467,051,911.16 | 491,681,992.86 |
| 应收票据及应收账款 | 136,519,224.34 | 188,470,063.65 | 136,701,788.26 | 108,700,571.56 |
| 应收账款 | 136,519,224.34 | 188,470,063.65 | 136,701,788.26 | 108,700,571.56 |
| 预付款项 | 25,750,620.54 | 3,652,874.44 | 27,758,229.85 | 46,335,633.77 |
| 其他应收款合计 | 9,739,196.62 | 2,748,330.44 | 10,243,116.81 | 13,628,102.8 |
| 存货 | 136,462,358.12 | 129,819,999.01 | 110,341,988.6 | 96,313,859.74 |
| 其他流动资产 | 13,703,400.28 | 13,555,355.14 | 12,948,801.23 | 11,325,176.09 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 779,673,740.26 | 797,452,518.69 | 765,045,835.91 | 767,985,336.82 |
| 非流动资产: | | | | |
| 长期股权投资 | 37,430,011.79 | 38,065,734.12 | 38,672,805.36 | 32,958,059.02 |
| 其他权益工具投资 | 29,306,015.02 | 29,371,925.12 | 28,648,010.52 | 28,735,525.68 |
| 投资性房地产 | 186,732,197.34 | 188,364,715.28 | 178,613,484.75 | 180,148,852.77 |
| 固定资产 | 500,563,396.02 | 508,958,149.5 | 414,616,246.51 | 419,318,155.95 |
| 在建工程 | 37,098,859.27 | 22,707,812.49 | 119,563,539.22 | 98,744,447.3 |
| 使用权资产 | 1,145,263.08 | 1,260,285.7 | 405,569.08 | 856,630.79 |
| 无形资产 | 52,563,339.63 | 52,384,409.59 | 52,666,819.33 | 52,980,250.28 |
| 递延所得税资产 | 6,928,624.14 | 6,918,737.62 | 5,610,147.64 | 5,325,817.45 |
| 其他非流动资产 | 73,103,004.65 | 56,538,811.22 | 27,105,724.81 | 37,695,061.61 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 924,870,710.94 | 904,570,580.64 | 865,902,347.22 | 856,762,800.85 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,704,544,451.2 | 1,702,023,099.33 | 1,630,948,183.13 | 1,624,748,137.67 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 42,315,187.95 | 51,925,868.87 | 28,438,544.17 | 36,362,244.6 |
| 应付账款 | 42,315,187.95 | 51,925,868.87 | 28,438,544.17 | 36,362,244.6 |
| 预收款项 | 5,516,226.2 | 5,698,849.83 | 218,493.32 | 90,217.51 |
| 合同负债 | 14,746,115.33 | 13,745,864.41 | 15,608,014.68 | 17,634,128.95 |
| 应付职工薪酬 | 17,303,023.18 | 17,385,354.43 | 9,762,786.33 | 8,751,125.17 |
| 应交税费 | 8,471,221.51 | 20,130,806.07 | 9,319,273.94 | 6,168,036.91 |
| 其他应付款合计 | 4,115,822.68 | 7,115,317.35 | 18,434,897.23 | 24,506,865.53 |
| 应付股利 | - | - | 1,268,669.28 | 10,014,676.51 |
| 一年内到期的非流动负债 | 4,395,688.05 | 3,027,210.53 | 1,683,272.38 | 1,660,139.82 |
| 其他流动负债 | 180,053.81 | 305,092.1 | 288,957.15 | 319,541.52 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 97,043,338.71 | 119,334,363.59 | 83,754,239.2 | 95,492,300.01 |
| 非流动负债: | | | | |
| 应付债券 | 365,466,585.02 | 359,884,472.26 | 354,093,351.97 | 348,270,499.56 |
| 租赁负债 | 366,464.02 | 386,276.41 | 87,103.91 | 188,994.38 |
| 递延收益 | 27,323,365.72 | 25,342,710.72 | 23,615,819.12 | 24,631,784.66 |
| 递延所得税负债 | 35,283.19 | 35,283.19 | 35,283.19 | 35,283.19 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 393,191,697.95 | 385,648,742.58 | 377,831,558.19 | 373,126,561.79 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 490,235,036.66 | 504,983,106.17 | 461,585,797.39 | 468,618,861.8 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 140,363,220 | 140,363,220 | 140,363,220 | 140,363,220 |
| 其他权益工具 | 129,905,536.4 | 129,905,536.4 | 129,905,536.4 | 129,905,536.4 |
| 资本公积 | 413,561,970.81 | 413,561,970.81 | 413,562,031.59 | 413,562,031.59 |
| 减:库存股 | 30,000,946.05 | 30,000,946.05 | 30,000,946.05 | 21,453,047.61 |
| 其他综合收益 | 1,175,800.64 | 1,231,824.22 | 678,778.95 | 514,596.83 |
| 盈余公积 | 68,949,063.29 | 68,949,063.29 | 60,562,454.98 | 60,562,454.98 |
| 未分配利润 | 482,231,735.31 | 465,769,398.4 | 452,123,235.92 | 431,966,650.5 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,206,186,380.4 | 1,189,780,067.07 | 1,167,194,311.79 | 1,155,421,442.69 |
| 少数股东权益 | 8,123,034.14 | 7,259,926.09 | 2,168,073.95 | 707,833.18 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,214,309,414.54 | 1,197,039,993.16 | 1,169,362,385.74 | 1,156,129,275.87 |
| 负债和股东权益合计 | 1,704,544,451.2 | 1,702,023,099.33 | 1,630,948,183.13 | 1,624,748,137.67 |
| 公告日期 | 2025-04-26 | 2025-04-16 | 2024-10-24 | 2024-08-24 |
| 审计意见(境内) | | 标准无保留意见 | | |